Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses.

The study investigates the efficiency of specific drugs in minimizing the negative side effects of imidocarb dipropionate in horses with piroplasmosis. It observed that a combination of butylscopolammonium bromide and metamizole sodium might help in reducing these adverse effects, although the observed difference wasn’t significantly different from the control group due to the small group size.

Methods Used in Research

• The study involved 28 horses diagnosed with piroplasmosis. They were randomly divided equally into four groups, each receiving a different pretreatment before being administered with imidocarb dipropionate.
• The first group was pretreated with atropine sulfate, the second with a combination of butylscopolammonium bromide, and metamizole sodium, the third with flunixin meglumine, and the fourth (control group) received a saline solution.
• A thorough physical examination was done on each horse, tracking vital signs such as rectal temperature, heart, and respiratory rates, capillary refill time, mucous membrane color, hydration status, and abdominal sounds. The researchers also observed signs of abdominal pain, salivation, diarrhea, and frequency of defecation.

Results of the Study

• The use of imidocarb dipropionate, an anti-parasitic drug, resulted in serious side effects in the control group, including signs of abdominal pain and diarrhea.
• Horses pretreated with atropine sulfate didn’t display signs of diarrhea, but many exhibited signs of abdominal pain.
• Only one horse that received butylscopolammonium bromide and metamizole sodium showed signs of abdominal pain and three had diarrhea. The difference was not statistically significant from that of the control group but was numerically different.
• Three horses pretreated with flunixin meglumine showed signs of abdominal pain and diarrhea.

Conclusion of the Research

• The authors concluded that the combination of butylscopolammonium bromide and metamizole sodium might be effective in reducing the side effects of imidocarb dipropionate in horses.
• However, the group sizes were small, and the differences from the control group were not found to be statistically significant, thereby limiting the confidence in these findings.